Facts about Heron Therapeutics Inc (HRTX) Stock that you might not know

Needham raised the price target for the Heron Therapeutics Inc (NASDAQ:HRTX) stock to “a Buy”. The rating was released on March 13, 2024, according to finviz. The research report from Needham has reiterated the stock to Buy, with a price target set at $48. The stock was reiterated by Needham, who disclosed in a research […]

Is Heron Therapeutics Inc (HRTX) Stock worth its current valuation?

Guggenheim raised the price target for the Heron Therapeutics Inc (NASDAQ:HRTX) stock to “a Buy”. The rating was released on May 27, 2020, according to finviz. We previously noted in another research note published on February 20, 2020 by Needham that reiterated the stock to a Buy with a price target of $48 for HRTX […]

Heron Therapeutics Inc (HRTX) Stock deserves your attention

Guggenheim raised the price target for the Heron Therapeutics Inc (NASDAQ:HRTX) stock to “a Buy”. The rating was released on May 27, 2020, according to finviz. We previously noted in another research note published on February 20, 2020 by Needham that reiterated the stock to a Buy with a price target of $48 for HRTX […]

What Are the Chances of Heron Therapeutics Inc (HRTX) Stock Making a Comeback?

Guggenheim raised the price target for the Heron Therapeutics Inc (NASDAQ:HRTX) stock to “a Buy”. The rating was released on May 27, 2020, according to finviz. We previously noted in another research note published on February 20, 2020 by Needham that reiterated the stock to a Buy with a price target of $48 for HRTX […]

Hold on to your shares: Heron Therapeutics Inc (HRTX) Stock

Guggenheim raised the price target for the Heron Therapeutics Inc (NASDAQ:HRTX) stock to “a Buy”. The rating was released on May 27, 2020, according to finviz. We previously noted in another research note published on February 20, 2020 by Needham that reiterated the stock to a Buy with a price target of $48 for HRTX […]

Heron Therapeutics Inc (NASDAQ:HRTX) Stock is trading at a margin of 17.23% From 20-Day SMA

Guggenheim raised the price target for the Heron Therapeutics Inc (NASDAQ:HRTX) stock to “a Buy”. The rating was released on May 27, 2020, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report as stock price […]

Does A Technical Metric Suggest That Heron Therapeutics Inc (HRTX) Stock Is Ready To Rise?

Guggenheim raised the price target for the Heron Therapeutics Inc (NASDAQ:HRTX) stock to “a Buy”. The rating was released on May 27, 2020, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report as stock price […]